Kornitzer Capital Management’s Cardlytics CDLX Stock Holding History

Kornitzer Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-19,468	Closed	-$27.8M	–	495
2020 Q4	$27.8M	Sell	19,468 -1,830	-9%	-$1.95M	0.47%	66
2020 Q3	$15M	Buy	21,298 +19,998	+1,538%	+$14.5M	0.29%	122
2020 Q2	$910K	Hold	1,300	–	–	0.02%	410
2020 Q1	$454K	Sell	1,300 -15,046	-92%	-$10.7M	0.01%	451
2019 Q4	$10.3M	Sell	16,346 -2,165	-12%	-$1.06M	0.18%	167
2019 Q3	$6.21M	Buy	18,511 +8,971	+94%	+$2.88M	0.11%	238
2019 Q2	$2.48M	Hold	9,540	–	–	0.04%	315
2019 Q1	$1.58M	Hold	9,540	–	–	0.03%	345
2018 Q4	$1.03M	Sell	9,540 -230	-2%	-$38.8K	0.02%	374
2018 Q3	$2.45M	Buy	9,770 +1,970	+25%	+$424K	0.04%	307
2018 Q2	$1.7M	Buy	7,800 +1,700	+28%	+$315K	0.03%	338
2018 Q1	$892K	Buy	+6,100	New	+$1.03M	0.02%	390

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kornitzer Capital Management's CDLX Position: Q1 2021 in Review

Kornitzer Capital Management sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 19,468 shares — an estimated $27.8M sold.

Kornitzer Capital Management first reported a position in CDLX in Q1 2018 and held it in 12 quarters. The position peaked at $27.8M in Q4 2020. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.

Kornitzer Capital Management reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
Kornitzer Capital Management sold 19,468 Cardlytics shares in Q1 2021, an estimated $27.8M.
Kornitzer Capital Management first reported a position in Cardlytics in Q1 2018 and held it in 12 quarters.
Kornitzer Capital Management's Cardlytics position peaked at $27.8M in Q4 2020.
204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.

Based on Kornitzer Capital Management's 13F filing for Q1 2021, filed 30 Apr 2021.